[Designation名稱] NTCC? ID HEK293SF-3F6 Cell Line細胞株
BioVector NTCC Inc.

DR ATCC; CRL-3537
DR ATCC; CRL-12585
SY HEK293-SF-3F6; HEK 293SF-3F6; 293SF-3F6
DR Wikidata; Q54882487
RX Patent=US6210922;
RX PubMed=10099373;
RX PubMed=31548015;
WW https://web.archive.org/web/20190105224206/http://www.nrc-cnrc.gc.ca/eng/solutions/licensing/10894.html
WW https://www.canada.ca/en/national-research-council/news/2020/05/the-national-research-council-of-canada-and-cansino-biologics-inc-announce-collaboration-to-advance-vaccine-against-covid-19.html
CC Group: Patented cell line.
CC Group: Serum/protein free medium cell line.
CC Group: Vaccine production cell line.
CC Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12585.
[Organism物種來源]
[Disease疾病種類]
[Accession編號] NTCC?-AC CVCL_4V95
[Comments描述]
[Reference參考文獻]
[Category分類]
[Date保藏時間]
[Synonyms別名]
[Hierarchy]
培養方法：
Medium培養基：NTCC? ID HEK293SF-3F6 Complete Medium
Growth properties形態：貼壁/懸浮：
Culture Condition培養條件：Temperature溫度: 37°C.
Atmosphere: 95% Air, 5% CO2

Supplier生產廠家: BioVector NTCC質粒載體菌種細胞蛋白抗體基因保藏中心
Website網址：www.biovector.net